<DOC>
	<DOCNO>NCT02450461</DOCNO>
	<brief_summary>The purpose study answer question whether disease-specific profile breath patient asthma detect untargeted metabolomic study use exhale breath analysis mass spectrometry .</brief_summary>
	<brief_title>Breath Analysis Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>1 . Confirmed asthma . Diagnosis asthma make episodic chest symptom document reversibility least 12 % and/or 200 ml FEV1 200 ug inhale salbutamol airway hyperresponsiveness case normal lung function test ( PC20 methacholine &lt; 4mg/ml ) time diagnosis . 2 . Age 18 80 year study entry . 3 . Healthy control : neversmokers , normal spirometry ( baseline FEV1 &gt; 85 % predict FEV1/FVC great 0.7 ) . 1 . Asthma exacerbation within last 6 week , define worsen asthma symptom require change therapy physician change regular asthma therapy ( include short course oral corticosteroid ) 2 . Any lung disease asthma . 3 . Acute inflammatory disease ( e.g . common cold ) within last 4 week . 4 . Regular intake oral steroid . 5 . Active smoking habit / positive history smoking . 6 . Acute chronic hepatic disease . 7 . Renal failure renal replacement therapy . 8 . Pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>